Re: Xarelto vs Lovenox in immobilized patients (MAGELLAN study) Xarelto is probably dead in this indicationWe're yet to see if Apixaban can produce a better profile (I think it has a better shot) in this indication from this study: http://clinicaltrials.gov/show/NCT00457002